Intra-Cellular Therapies Inc (ITCI) Testing Investors’ Patience Right Now
Currently, there are 106.00M common shares owned by the public and among those 99.09M shares have been available to trade. The company’s stock has a 5-day price change of 51.92% and 72.79% over the past three months. ITCI shares are trading 52.29% year to date (YTD), with the 12-month market performance up to 88.21% higher. […]
